Despite clinical treatment guidelines recommending routine EGFR testing for all patients with metastatic NSCLC of non-SCC histology [6–8], here only 71% of newly diagnosed patients underwent EGFR testing prior to EGFR-TKI initiation. Here, EGFR is linked to non-small cell lung carcinoma.